Mon, December 18, 2023
Fri, December 15, 2023
Thu, December 14, 2023
Wed, December 13, 2023
Tue, December 12, 2023

Subbu Nambi Initiated (TXG) at Strong Buy and Held Target at $60 on, Dec 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-60-on-dec-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Subbu Nambi of Guggenheim, Initiated "10x Genomics, Inc." (TXG) at Strong Buy and Held Target at $60 on, Dec 14th, 2023.

Subbu has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 1 agrees with Subbu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derik De Bruin of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $54 on, Tuesday, December 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Subbu


  • Doug Schenkel of "Wolfe Research" Initiated at Buy on, Wednesday, December 13th, 2023
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $47 on, Friday, September 29th, 2023
  • Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $70 on, Tuesday, September 19th, 2023

Publication Contributing Sources